Education
About Us
Working with TipRanks
Follow Us
Microba Life Sciences Limited (AU:MAP)
ASX:MAP
RESEARCH TOOLSreports
Total Valuation
Microba Life Sciences Limited has a market cap or net worth of AU$73.90M. The enterprise value is ―.
Market CapAU$73.90M
Enterprise Value―
Share Statistics
Microba Life Sciences Limited has 447,852,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding447,852,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Microba Life Sciences Limited’s return on equity (ROE) is -0.48 and return on invested capital (ROIC) is -57.11%.
Return on Equity (ROE)-0.48
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-57.11%
Return on Capital Employed (ROCE)-0.59
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.21
Inventory Turnover2.76
Valuation Ratios
The current PE Ratio of Microba Life Sciences Limited is -3.33. Microba Life Sciences Limited’s PEG ratio is -0.11.
PE Ratio-3.33
PS Ratio0.00
PB Ratio2.13
Price to Fair Value1.61
Price to FCF-6.26
Price to Operating Cash Flow-8.79
PEG Ratio-0.11
Income Statement
In the last 12 months, Microba Life Sciences Limited had revenue of 12.09M and earned -19.94M in profits. Earnings per share was -0.05.
Revenue12.09M
Gross Profit5.91M
Operating Income-26.84M
Pretax Income-19.99M
Net Income-19.94M
EBITDA-17.10M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -6.66M and capital expenditures -2.84M, giving a free cash flow of -9.50M billion.
Operating Cash Flow-6.66M
Free Cash Flow-9.50M
Free Cash Flow per Share-0.02
Dividends & Yields
Microba Life Sciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change-25.00%
50-Day Moving Average0.18
200-Day Moving Average0.20
Relative Strength Index (RSI)40.93
Average Volume (3m)154.73K
Important Dates
Microba Life Sciences Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Microba Life Sciences Limited as a current ratio of 2.61, with Debt / Equity ratio of 9.72%
Current Ratio2.61
Quick Ratio2.43
Debt to Market Cap<0.01
Net Debt to EBITDA1.13
Interest Coverage Ratio-387.79
Taxes
In the past 12 months, Microba Life Sciences Limited has paid -51.30K in taxes.
Income Tax-51.30K
Effective Tax Rate<0.01
Enterprise Valuation
Microba Life Sciences Limited EV to EBITDA ratio is -2.75, with an EV/FCF ratio of -2.36.
EV to Sales3.89
EV to EBITDA-2.75
EV to Free Cash Flow-2.36
EV to Operating Cash Flow-3.02
Balance Sheet
Microba Life Sciences Limited has AU$17.45M in cash and marketable securities with AU$3.47M in debt, giving a net cash position of -AU$13.98M billion.
Cash & Marketable SecuritiesAU$17.45M
Total DebtAU$3.47M
Net Cash-AU$13.98M
Net Cash Per Share-AU$0.03
Tangible Book Value Per ShareAU$0.05
Margins
Gross margin is 8.93%, with operating margin of -222.02%, and net profit margin of -164.92%.
Gross Margin8.93%
Operating Margin-222.02%
Pretax Margin-165.34%
Net Profit Margin-164.92%
EBITDA Margin-141.45%
EBIT Margin-165.19%
Analyst Forecast
The average price target for Microba Life Sciences Limited is AU$0.34, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$0.34
Price Target Upside112.50% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast158.37%
EPS Growth Forecast36.73%